Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential

Cristina Fernandez,1 Clare L van Halsema1,21Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK; 2Faculty of Education, Liverpool School of Tropical Medicine, Liverpool, UKAbstract: Cabotegravir and rilpivirine long-acting injectable antiretroviral therapy for the tr...

Full description

Bibliographic Details
Main Authors: Fernandez C, van Halsema CL
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:HIV/AIDS: Research and Palliative Care
Subjects:
antiretroviral therapy
integrase inhibitors
non-nucleoside reverse transcriptase inhibitors
Online Access:https://www.dovepress.com/evaluating-cabotegravirrilpivirine-long-acting-injectable-in-the-treat-peer-reviewed-article-HIV

Internet

https://www.dovepress.com/evaluating-cabotegravirrilpivirine-long-acting-injectable-in-the-treat-peer-reviewed-article-HIV

Similar Items